Page 111 - Neuropsychiatric.indd

76. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137-45.
77. Velamoor VR. Neuroleptic malignant syndrome. recognition, prevention and management.

Drug Saf. 1998;19(1):73-82.
78. ศรินทิพย์ ศิริสุวรรณรัตน์. กลุ่มอาการ Neuroleptic malignant syndrome: การทบทวนเอกสารและ
รายงานผู้ป่วย 6 ราย. วารสารโรงพยาบาลเจริญกรุงประชารักษ์. 2563;16(1):1-23.
79. Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert

Opin Drug Saf. 2008;7(5):587-96.
80. Boyer EW. Serotonin syndrome (serotonin toxicity). [accessed 29 November 2020].
Available from: https://www.uptodate.com/contents/serotonin-syndrome-serotonin-

toxicity#H7
81. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity
Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM.
2003;96(9):635-42.
82. Ellahi R. Serotonin syndrome: A spectrum of toxicity. BJPsych Advances. 2015;21(5), 324-

32.
83. Ables AZ, Nagubilli R. Prevention, diagnosis, and management of serotonin syndrome. Am
Fam Physician. 2010;81(9):1139-42.

84. Liu Y, Yang H, He F, Xu P, Tong H, Liu Y, et al. An atypical case of serotonin syndrome with
normal dose of selective serotonin inhibitors: A case report. Medicine (Baltimore).
2019;98(19):e15554.
85. Tinroongroj N, Sukonthasarn A. Serotonin syndrome: a case report. BKK Med J.2016;

12(1):58.
86. Chen JJ, Dashtipour K, Swope DM. Chapter 12 Movement disorder. In: Tisdale JE et al., eds.
Drug-Induced Diseases: Prevention, Detection, and Management. 3rd ed. United States:
American Society of Health-System Pharmacists, Inc., 2018.

87. D'Souza RS, Hooten WM. Extrapyramidal symptoms. [accessed 29 November 2020].
Available from: https://www.ncbi.nlm.nih.gov/books/NBK534115/
88. Claxton KL, Chen JJ, Swope DM. Drug-induced movement disorders. J Pharm Pract.
2007;20(6):415-29.

89. Mehta SH, Morgan JC, Sethi KD. Drug-induced movement disorders. Neurol Clin.
2015;33(1):153-74.
90. Duma SR, Fung VS. Drug-induced movement disorders. Aust Prescr. 2019;42(2):56-61.
91. David M. Gardner and Michael D. Antipsychotics and their side effects. Cambridge:

Cambridge University Press, 2010.
92. Barnes TR: A Rating Scale for Drug-Induced Akathisia. Br J Psychiatry. 1989;154:672-6.
93. Factor SA, Leffler JB, Murray CF. Drug-induced movement disorder: A clinical review.
[accessed 2 October 2020]. Available from: https://www.medscape.org/viewarticle/586881

90
90